Enhanced Virgin Coconut Oil (EVCO) as Natural Postmilking Teat Germicide to Control Environmental Mastitis Pathogens

Authors

  • Koh Soo Peng Biotechnology & Nanotechnology Research Centre, Malaysian Agricultural Research & Development Institute (MARDI) PO Box 12301, 50774 Kuala Lumpur, Malaysia
  • Dahlia Harun Bacteriology Section, Veterinary Research Institute (VRI), 59, Jalan Sultan Azlan Shah, 31400 Ipoh, Perak, Malaysia
  • Maswati Mat Amin Bacteriology Section, Veterinary Research Institute (VRI), 59, Jalan Sultan Azlan Shah, 31400 Ipoh, Perak, Malaysia
  • Kamariah Long Biotechnology & Nanotechnology Research Centre, Malaysian Agricultural Research & Development Institute (MARDI) PO Box 12301, 50774 Kuala Lumpur, Malaysia

DOI:

https://doi.org/10.6000/1927-3037.2016.05.04.2

Keywords:

Mastitis, Enhanced Virgin Coconut Oil (EVCO), Mastivet, Antimicrobial Activity.

Abstract

The antimicrobial capability of oil containing medium-chain fatty acids and their corresponding monoglycerides, known as Enhanced Virgin Coconut Oil (EVCO) against microorganisms isolated from bovine mastitis milk was studied. EVCO contains an effective amount of medium-chain free fatty acids (caprylic, capric and lauric acid) and their corresponding derivatives (monocaprylin, monocaprin and monolaurin) can act as antimicrobial agent with broad spectrum of antimicrobial properties. An in vitro assessment of EVCO against bovine mastitis microorganisms isolated from locally collected mastitis milk samples was conducted to determine its minimum bactericidal concentration (MBC>99). In general, EVCO exhibited its great antimicrobial capability to kill all mastitis microorganisms isolated from the mastitis milk sample at different concentrations of MBC>99 value. In fact, EVCO was found more effective to kill Mycoplasma sp. and gram positive microbes rather than gram negative microbes, especially in Mycoplasma bovis, Acholeplasma oculi, Enterococcus sp., Streptococcus sp. and Staphylococcus aureus with lower MBC>99 values in comparison with the synthetic antibiotic, Mastivet. A further investigation of the antimicrobial activities of EVCO against Staphylococcus aureus and Mycoplasma bovis against time revealed that EVCO was more efficient in killing these two microorganisms in a shorter time at a lower concentration as opposed to Mastivet. These findings indicated that EVCO has great potential application in postmilking teat germicide, which can be used as a preventive measure to control mastitis cases, especially against environmental mastitis pathogens.

References

Costal EO, Melville PA, Ribeiro AR, Watanabe ET, Parolari MC. Epidemiologic study of environmental sources of a Protothecazopfii outbreak of bovine mastitis. Mycopathologia 1997; 137: 33-6. http://dx.doi.org/10.1023/A:1006871213521

Moretti A, Pasquali P, Mencaroni G, Boncio L, Fioretti D P. Relationship between cell counts in bovine milk and the presence of mastitis pathogens (yeast and bacteria). Zentralbl Veterinarmed [B] 1998; 45: 129-32. http://dx.doi.org/10.1111/j.1439-0450.1998.tb00775.x

Bradley AJ, Green MJ. Aetiology of clinical mastitis in six Somerset dairy herds. Vet Rec 2001; 148: 683-6. http://dx.doi.org/10.1136/vr.148.22.683

Jasper DE. Bovine mycoplasmal mastitis. Adv Vet Sci Comp Med 1981; 25: 121-6.

Fang W, Shi M, Huang L, Shao Q, Chen J. Growth of Lactobacilli, Staphylococcus aureus and Escherichia coli in normal and mastitic milk and whey. Vet Microbiol 1993; 37: 115-25. http://dx.doi.org/10.1016/0378-1135(93)90186-B

Leitner G, Lubashevsky E, Trainin Z. Staphylococcus aureus vaccine against mastitis in dairy cows, composition and evaluation of its immunogenicity in a mouse model. Vet. Immunol Immunopathol 2003; 93: 159-67. http://dx.doi.org/10.1016/S0165-2427(03)00069-2

Grőhn YT, Wilson DJ, González RN, Hertl JA, Schulte H, Bennett G, Schukken YH. Effect of pathogen-specific clinical mastitis on milk yield in milk yield in dairy cows. J Dairy Sci 2004; 87: 3358-74. http://dx.doi.org/10.3168/jds.S0022-0302(04)73472-4

Filioussis G, Christodoulopoulos G, Thatcher A, Petridou V, Bourtzi-Chatzopoulou E. Isolation of Mycoplasma bovis from bovine clinical mastitis cases in Northern Greece. Vet J 2007; 173: 215-8. http://dx.doi.org/10.1016/j.tvjl.2005.08.001

Fadlelmula A, AL Dughaym AM, Mohamed GE, AL Deib MK, Zubaidy AJ. Bovine mastitis: epidemiological, clinical and etiological study in a Saudi Arabian large dairy farm. Bulgarian J Vet Med 2009; 12: 199-206.

Anderson N. Dairy Barns and Mastitis, in Infosheet from OMAFRA: Dairy Cow Comfort 2008; 1-8.

Bramley AJ. The effect of sub-clinical Staphylococcus epidermidis infection of the lactating bovine udder on its susceptibility to infection with Streptococcus agalactiae or Escherichia coli. Br Vet J 1978; 34: 146-51.

Brouillette E, Malouin F. The pathogenesis and control of Staphylococcus aureus-induced mastitis: study models in the mouse. Microb Infect 2005; 7: 560-8. http://dx.doi.org/10.1016/j.micinf.2004.11.008

Ayling RD, Bashiruddin JB, Nicholas RA. Mycoplasma species and related organisms isolated from ruminants in Britain between 1990 and 2000. Vet Rec 2004; 155: 413-6. http://dx.doi.org/10.1136/vr.155.14.413

Bryne W, Markey B, McCormack R, Egan J, Ball H, Sachse K. Persistence of Mycoplasma bovis infection in the mammary glands of lactating cows inoculated experimentally. Vet Rec 2005; 156: 767-71. http://dx.doi.org/10.1136/vr.156.24.767

Kabara JJ, Swieczkowski DM, Conley AJ, Truant JP. Fatty acids and derivatives as antimicrobial agents. Antimicrob Agents Chemother 1972; 2: 23-8. http://dx.doi.org/10.1128/AAC.2.1.23

Dee A, Gradle C. Fatty acid antimicrobial. US patent 2004/0167221A1. 2004.

Richter FL, Reinhardt DJ. Antimicrobial compositions formulated for use in cold temperature conditions and method of use thereof. US patent 7109241 B1, 2006.

Long K. Modified coconut oils with broad antimicrobial spectrum. Malaysian Granted Patent MY140578-A. 2009

Hart ER. Cleaner leaving an antimicrobial film. US patent 2006/0030512 A1. 2006.

Tan GH, Long K. Preliminary study of anticoccidial activity of medium chain fatty acids (MCFA) and their corresponding monoglycerides on broiler chicken coccidiosis. International Journal of Biotechnology for Wellness Industries 2012; 1: 134-41. http://dx.doi.org/10.6000/1927-3037/2012.01.02.05

Quinn PJ, Carter ME, Markey BK, Carter GR. Clinical Veterinary Microbiology. London: Mosby-Year Europe Limited; 1994: pp 21-66 & 327-344.

Tan LJ. Diagnostic technique on mammalian Mycoplasma. In: Laboratory Working Manual. Malaysia: Veterinary Research Institute; 1986

Koh SP, Long K. The antimicrobial activity of Enhanced Virgin Coconut Oil (EVCO) on growth of mastitis growth pathogens. Malaysian Journal of Microbiology. 2014; 10:112-8.

Farnsworth RJ, Sorensen DK. Prevalence and species distribution of yeast in mammary glands of dairy cows in Minnesota. Can J Comp Med 1972; 36: 329-32.

Chahota R, Katoch R, Mahajan A, Subhash V. Clinical bovine mastitis caused by Geotrichum candidum. Veterinarski Arhiv 2001; 71: 197-201

Blackmer PE. Mycoplasma bovis in large dairy herds: sharing 28 years of practice experience. In: Proceedings of 84th Annual Conference. Wisconsin Veterinary Medical Association, Medison, PA, 1998: pp. 145.

Anita R, Thilo K, Paul W, Peter R. Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients. Antimicrob Agents Chemother 2007; 51: 1341-50. http://dx.doi.org/10.1128/AAC.01278-06

Downloads

Published

2016-12-05

How to Cite

Peng, K. S., Harun, D., Amin, M. M., & Long, K. (2016). Enhanced Virgin Coconut Oil (EVCO) as Natural Postmilking Teat Germicide to Control Environmental Mastitis Pathogens. International Journal of Biotechnology for Wellness Industries, 5(4), 128–134. https://doi.org/10.6000/1927-3037.2016.05.04.2

Issue

Section

Articles